U.S. TCM Company Acquires Chinese Firm’s Product Line
This article was originally published in PharmAsia News
SHANGHAI - China Sky One Medical will pay $8.3 million to Heilongjiang Tianlong Pharmaceutical, for the acquisition of Tianlong Pharmaceutical
You may also be interested in...
BEIJING - China Sky One Medical reported first quarter revenue of $12.4 million, marking a 140 percent increase year on year, the company told a May 15 earnings call
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).